Skip to main content

Pfizer To Buy Array BioPharma For $48/Share

Array BioPharma shares are trading sharply higher after the company announced it will be acquired by Pfizer for $48 per share in cash for a total value of around $11.4 billion.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.